Search Results - "Mountain, Angela"

Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806 by Lee, Fook T, O'Keefe, Graeme J, Gan, Hui K, Mountain, Angela J, Jones, Gareth R, Saunder, Timothy H, Sagona, Jessica, Rigopoulos, Angela, Smyth, Fiona E, Johns, Terrance G, Govindan, Serengulam V, Goldenberg, David M, Old, Lloyd J, Scott, Andrew M

“…Overexpression, activation, and mutations of the epidermal growth factor receptor (EGFR) are commonly found in solid tumors. The aim of this study was to…”
Get full text

Enhanced Efficacy of Radioimmunotherapy with 90Y-CHX-A″-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478 by LEE, Fook T, MOUNTAIN, Angela J, SCOTT, Andrew M, KELLY, Marcus P, HALL, Cathrine, RIGOPOULOS, Angela, JOHNS, Terrance G, SMYTH, Fiona E, BRECHBIEL, Martin W, NICE, Edouard C, BURGESS, Antony W

“…Purpose: Monoclonal antibodies and tyrosine kinase inhibitors specific for the epidermal growth factor receptor (EGFR) have been shown to enhance the effect of…”
Get full text

Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma by CHONG, Geoffrey, LEE, Fookthean, MURPHY, Roger, WIRTH, Veronika, SMYTH, Fiona E, POTASZ, Nicole, POON, Aurora, DAVIS, Ian D, SAUNDER, Tim, O'KEEFE, Graeme J, BURGESS, Antony W, HOFFMAN, Eric W, HOPKINS, Wendie, OLD, Lloyd J, SCOTT, Andrew M, TEBBUTT, Niall, CEBON, Jonathan S, MOUNTAIN, Angela J, CHAPPELL, Bridget, PAPENFUSS, Anthony, SCHLEYER, Paul, PAUL, U

“…Purpose: Humanized monoclonal antibody A33 (huA33) targets the A33 antigen which is expressed on 95% of colorectal cancers. A previous study has shown…”
Get full text

Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma by Scott, Andrew M, Liu, Zhanqi, Murone, Carmel, Johns, Terrance G, MacGregor, Duncan, Smyth, Fiona E, Lee, Fook-Thean, Cebon, Jonathan, Davis, Ian D, Hopkins, Wendie, Mountain, Angela J, Rigopoulos, Angela, Hanai, Nobuo, Old, Lloyd J

“…We conducted an open label dose-escalation phase I trial of chimeric anti-GD3 mAb KM871 in patients with metastatic melanoma. Patients were entered into one of…”
Get full text

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer by Dreyer, Stephan B., Upstill-Goddard, Rosie, Paulus-Hock, Viola, Paris, Clara, Dray, Eloise, Serrels, Bryan, Caligiuri, Giuseppina, Caligiuri, Giuseppina, Rebus, Selma, Plenker, Dennis, Brunton, Holly, Wright, Derek W., McKay, Colin J., Gulati, Aditi, Pettitt, Stephan, Bailey, Peter J., Chang, David K., Cooke, Susanna L., Dreyer, Stephan, Kelly, Shane, Marshall, John, McDade, Brian, Nourse, Craig, Paulus-Hock, Viola, Westwood, Paul, Biankin, Andrew V., Brancato, Mary-Anne L., Chin, Venessa T., Cowley, Mark J., Mead, R. Scott, Nagrial, Adnan M., Pettit, Jessica, Pinese, Mark, Rooman, Ilse, Tao, Jiang, DiPietro, Renee, Watson, Clare, Wong, Rachel, Giry-Laterriere, Marc, Grimmond, Sean M., Waddell, Nicola, Kassahn, Karin S., Patch, Ann-Marie, Idrisoglu, Senel, Nourbakhsh, Ehsan, Wani, Shivangi, Taylor, Darrin, Wood, Scott, Fink, J. Lynn, Bruxner, Tim, Cloonan, Nicole, Newell, Felicity, Pearson, John V., Bailey, Peter, Kazakoff, Stephen, Samra, Jaswinder S., Gill, Anthony J., Pavlakis, Nick, Asghari, Ray, Merrett, Neil D., Cosman, Peter H., Ismail, Kasim, McLeod, Duncan, James, Virginia, Kench, James G., Cooper, Caroline L., Sandroussi, Charbel, Gallagher, James, Texler, Michael, Forest, Cindy, Ballal, Mo, DeBoer, Bastiaan, Chai, Ming, Worthley, Chris, Tan, Chuan P., Martin, Patrick, Chiang, Amy, Yeung, Shinn, Hatzifotis, Michael, Christophi, Christopher, Biobank, Victorian Cancer, Hruban, Ralph H., Iacobuzio-Donahue, Christine A., Schulick, Richard D., Morgan, Richard A., Hodgin, Mary, Scarpa, Aldo, Lawlor, Rita T., Biankin, Andrew V., Grimmond, Sean M., Nourse, Craig, Johns, Amber, Pajic, Marina, Frame, Margaret C., Crawford, Howard C., Pilarsky, Christian, Morton, Jennifer P., Sansom, Owen J., Bailey, Peter J., Chang, David K.

“…Continuing recalcitrance to therapy cements pancreatic cancer (PC) as the most lethal malignancy, which is set to become the second leading cause of cancer…”
Get full text

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer by Brunton, Holly, Caligiuri, Giuseppina, Cunningham, Richard, Upstill-Goddard, Rosie, Garner, Ian M., Nourse, Craig, Wright, Derek W., Nixon, Colin, Jamieson, Nigel B., McGregor, Grant A., Evers, Lisa, McKay, Colin J., Gulati, Aditi, Brough, Rachel, Pettitt, Stephen J., Dziubinski, Michele L., Grützmann, Robert, Curry, Edward, Allison, Sarah, Biankin, Andrew V., Dreyer, Stephan, McDade, Brian, McElroy, Daniel, Ramsay, Donna, Upstill-Goddard, Rosie, Jamieson, Nigel B., Westwood, Paul, Mawson, Amanda, Scarlett, Christopher J., Brancato, Mary-Anne L., Simpson, Skye H., Thomas, Michelle T., Chin, Venessa T., Humphris, Jeremy L., Mead, R. Scott, Nagrial, Adnan M., Pettit, Jessica, Wu, Jianmin, DiPietro, Renee, Steinmann, Angela, Pinho, Andreia V., Giry-Laterriere, Marc, Musgrove, Elizabeth A., Miller, David K., Song, Sarah, Nourbakhsh, Ehsan, Wani, Shivangi, Gongora, Milena, Anderson, Matthew, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Bruxner, Tim, Pearson, John V., Nagaraj, Shivashankar, Kazakoff, Stephen, Waddell, Nick, Quek, Kelly, Pavlakis, Nick, Asghari, Ray, Pavey, Darren, Das, Amitabha, Ismail, Kasim, Lam, Vincent W., Richardson, Arthur, James, Virginia, Kench, James G., Joseph, David, Laycock, Andrew, Epari, Krishna P., Fletcher, David R., Zeps, Nikolajs, Beilin, Maria, Feeney, Kynan, Worthley, Chris, Tan, Chuan P., Debrencini, Tamara, Chen, John, Brooke-Smith, Mark E., Tang, Henry, Clouston, Andrew D., Fawcett, Jonathan W., Slater, Kellee, Hatzifotis, Michael, Nikfarjam, Mehrdad, Eshleman, James R., Hruban, Ralph H., Schulick, Richard D., Scarpa, Aldo, Scardoni, Maria, Tempero, Margaret A., Pajic, Marina, Petersen, Gloria M., Shanks, Emma, Pilarsky, Christian, Grimmond, Sean E., Morton, Jennifer P., Chang, David K., Bailey, Peter J., Biankin, Andrew V.

“…Pancreatic ductal adenocarcinoma (PDAC) can be divided into transcriptomic subtypes with two broad lineages referred to as classical (pancreatic) and squamous…”
Get full text

Weaving the Tapestry of Learning: Simulation, Standardized Patients, and Virtual Communities by Holland, Brian, Landry, Karen, Mountain, Angela, Middlebrooks, Mary Alice, Heim, Deborah, Missildine, Kathy

“…Using situated cognition learning theory, nursing faculty developed simulated clinical learning experiences integrating virtual communities and standardized…”
Get full text

Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET/CT by Lawrentschuk, Nathan, Lee, Fook T., Jones, Gareth, Rigopoulos, Angela, Mountain, Angela, O'Keefe, Graeme, Papenfuss, Anthony T., Bolton, Damien M., Davis, Ian D., Scott, Andrew M.

“…In tumors, hypoxia stimulates angiogenesis and correlates with treatment resistance and poor prognosis. We have previously demonstrated hypoxia in human renal…”
Get full text

Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using ^sup 124^I-IMP-R4-Labeled Antibody ch806 by Lee, Fook T, O'Keefe, Graeme J, Gan, Hui K, Mountain, Angela J, Jones, Gareth R, Saunder, Timothy H, Sagona, Jessica, Rigopoulos, Angela, Smyth, Fiona E, Johns, Terrance G, Giovindan, Serengulam V, Goldenberg, David M, Old, Lloyd J, Scott, Andrew M

“…Overexpression, activation, and mutations of the epidermal growth factor receptor (EGFR) are commonly found in solid tumors. The aim of this study was to…”
Get full text

Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using 124 I-IMP-R4–Labeled Antibody ch806 by Lee, Fook T., O'Keefe, Graeme J., Gan, Hui K., Mountain, Angela J., Jones, Gareth R., Saunder, Timothy H., Sagona, Jessica, Rigopoulos, Angela, Smyth, Fiona E., Johns, Terrance G., Govindan, Serengulam V., Goldenberg, David M., Old, Lloyd J., Scott, Andrew M.

Get full text

Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and124 I-cG250 PET/CT by Lawrentschuk, Nathan, F.R.A.C.S, Lee, Fook T., Ph.D, Jones, Gareth, B.Sc (Hons), Rigopoulos, Angela, M.Sc, Mountain, Angela, B.App.Sci, O'Keefe, Graeme, Ph.D, Papenfuss, Anthony T., Ph.D, Bolton, Damien M., M.D, Davis, Ian D., Ph.D, Scott, Andrew M., M.D

“…Abstract Objectives In tumors, hypoxia stimulates angiogenesis and correlates with treatment resistance and poor prognosis. We have previously demonstrated…”
Get full text

Enhanced Efficacy of Radioimmunotherapy with super(90)Y-CHX-A''-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478 by Lee, Fook T, Mountain, Angela J, Kelly, Marcus P, Hall, Cathrine, Rigopoulos, Angela, Johns, Terrance G, Smyth, Fiona E, Brechbiel, Martin W, Nice, Edouard C, Burgess, Antony W, Scott, Andrew M

“…PURPOSE: Monoclonal antibodies and tyrosine kinase inhibitors specific for the epidermal growth factor receptor (EGFR) have been shown to enhance the effect of…”
Get full text

Phase I Trial of super(131)I-huA33 in Patients with Advanced Colorectal Carcinoma by Chong, Geoffrey, Lee, Fook Thean, Hopkins, Wendie, Tebbutt, Niall, Cebon, Jonathan S, Mountain, Angela J, Chappell, Bridget, Papenfuss, Anthony, Schleyer, Paul, U, Paul, Murphy, Roger, Wirth, Veronika, Smyth, Fiona E, Potasz, Nicole, Poon, Aurora, Davis, Ian D, Saunder, Tim, O'Keefe, Graeme J, Burgess, Antony W, Hoffman, Eric W, Old, Lloyd J, Scott, Andrew M

“…PURPOSE: Humanized monoclonal antibody A33 (huA33) targets the A33 antigen which is expressed on 95% of colorectal cancers. A previous study has shown…”
Get full text

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system by RENNER, Christoph, STEHLE, Ingo, SCOTT, Andrew M, LEE, Fook Thean, HALL, Cathrine, CATIMEL, Bruno, NICE, Edouard C, MOUNTAIN, Angela, RIGOPOULOS, Angela, BRECHBIEL, Martin W, PFREUNDSCHUH, Michael

“…Bispecific antibodies are currently being used in clinical trials in increasing numbers in the areas of breast cancer, prostate cancer, non-Hodgkin's lymphoma…”
Get full text